Edition:
India

People: Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

1.75EUR
22 Oct 2019
Change (% chg)

€-0.01 (-0.68%)
Prev Close
€1.76
Open
€1.77
Day's High
€1.77
Day's Low
€1.74
Volume
17,012
Avg. Vol
66,205
52-wk High
€3.30
52-wk Low
€1.65

Ancel, Christophe 

Mr. Christophe Ancel has been Vice President - Responsible Pharmacist, Quality and Deputy CEO and Member of the Management Committee at Transgene since 2014. He joined Transgene in 2008 as Head of Quality Assurance, and then as Director of Operational Quality. Previously he worked as a quality consultant to a variety of international pharmaceutical laboratories. From 2001 to 2005 he was Quality Manager, Deputy Pharmacist and acting Responsible Pharmacist at the French production plant of E. Lilly. In 2001 he was Quality Manager and acting Qualified Pharmacist at a Cardinal Health plant. From 1992 to 2000, he worked at Alcon Laboratories in the quality area and was Deputy Pharmacist at their production site. His various professional experiences have led him to work in an international settings of sterile product manufacturing and marketing. He has a PhD in pharmacology.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --